Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2015, Article ID 671839, 9 pages
http://dx.doi.org/10.1155/2015/671839
Research Article

hCLOCK Causes Rho-Kinase-Mediated Endothelial Dysfunction and NF-κB-Mediated Inflammatory Responses

1Institute of Vascular Surgery, Department of Vascular Surgery, Zhongshan Hospital, Fudan University, Shanghai 200032, China
2Department of Physiology and Pathophysiology, Fudan University Shanghai Medical College, Shanghai 200032, China
3Department of Vascular Surgery, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai 200032, China

Received 16 March 2015; Accepted 21 May 2015

Academic Editor: Manuela Malatesta

Copyright © 2015 Xiao Tang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Paul, K. R. Saradalekshmi, A. M. Alex, and M. Banerjee, “Circadian rhythm of homocysteine is hCLOCK genotype dependent,” Molecular Biology Reports, vol. 41, no. 6, pp. 3597–3602, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Katzenberg, T. Young, L. Finn et al., “A CLOCK polymorphism associated with human diurnal preference,” Sleep, vol. 21, no. 6, pp. 569–576, 1998. View at Google Scholar · View at Scopus
  3. M. Doi, J. Hirayama, and P. Sassone-Corsi, “Circadian regulator CLOCK is a histone acetyltransferase,” Cell, vol. 125, no. 3, pp. 497–508, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Kume, M. J. Zylka, S. Sriram et al., “mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop,” Cell, vol. 98, no. 2, pp. 193–205, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. M. K. Bunger, L. D. Wilsbacher, S. M. Moran et al., “Mop3 is an essential component of the master circadian pacemaker in mammals,” Cell, vol. 103, no. 7, pp. 1009–1017, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. DeBruyne, E. Noton, C. M. Lambert, E. S. Maywood, D. R. Weaver, and S. M. Reppert, “A clock shock: mouse CLOCK is not required for circadian oscillator function,” Neuron, vol. 50, no. 3, pp. 465–477, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Chen, P. Liu, C. Li et al., “Deregulated expression of the clock genes in gliomas,” Technology in Cancer Research and Treatment, vol. 12, no. 1, pp. 91–97, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. A. E. Hoffman, C.-H. Yi, T. Zheng et al., “CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses,” Cancer Research, vol. 70, no. 4, pp. 1459–1468, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Mazzoccoli, A. Piepoli, M. Carella et al., “Altered expression of the clock gene machinery in kidney cancer patients,” Biomedicine and Pharmacotherapy, vol. 66, no. 3, pp. 175–179, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-M. Lin, J. H. Chang, K.-T. Yeh et al., “Disturbance of circadian gene expression in hepatocellular carcinoma,” Molecular Carcinogenesis, vol. 47, no. 12, pp. 925–933, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. K. T. Yeh, M. Y. Yang, T. C. Liu et al., “Abnormal expression of period 1 (PER1) in endometrial carcinoma,” Journal of Pathology, vol. 206, no. 1, pp. 111–120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. S. S. Sabharwal and P. T. Schumacker, “Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?” Nature Reviews Cancer, vol. 14, no. 11, pp. 709–721, 2014. View at Publisher · View at Google Scholar
  13. G. Waris and H. Ahsan, “Reactive oxygen species: role in the development of cancer and various chronic conditions,” Journal of Carcinogenesis, vol. 5, article 14, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. W.-L. Lee, J.-Y. Huang, and L.-F. Shyur, “Phytoagents for cancer management: regulation of nucleic acid oxidation, ROS, and related mechanisms,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 925804, 22 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. A. Saunders, L. C. Rogers, C. Klomsiri, L. B. Poole, and L. W. Daniel, “Reactive oxygen species mediate lysophosphatidic acid induced signaling in ovarian cancer cells,” Free Radical Biology and Medicine, vol. 49, no. 12, pp. 2058–2067, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Tong and V. Tergaonkar, “Rho protein GTPases and their interactions with NFκB: crossroads of inflammation and matrix biology,” Bioscience Reports, vol. 34, no. 3, pp. 283–295, 2014. View at Publisher · View at Google Scholar
  17. N. D. Perkins, “The diverse and complex roles of NF-κB subunits in cancer,” Nature Reviews Cancer, vol. 12, no. 2, pp. 121–132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Pasparakis, “Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases,” Nature Reviews Immunology, vol. 9, no. 11, pp. 778–788, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. U. C. S. Yadav and K. V. Ramana, “Regulation of NF-kappaB-induced inflammatory signaling by lipid peroxidation-derived aldehydes,” Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 690545, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. E. S. Williams, E. Wilson, and K. S. Ramos, “NF-κB and matrix-dependent regulation of osteopontin promoter activity in allylamine-activated vascular smooth muscle cells,” Oxidative Medicine and Cellular Longevity, vol. 2012, Article ID 496540, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Kheradmand, E. Werner, P. Tremble, M. Symons, and Z. Werb, “Role of rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change,” Science, vol. 280, no. 5365, pp. 898–902, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Perona, S. Montaner, L. Saniger, I. Sánchez-Pérez, R. Bravo, and J. C. Lacal, “Activation of the nuclear factor-κB by Rho, CDC42, and Rac-1 proteins,” Genes & Development, vol. 11, no. 4, pp. 463–475, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Perez-Moreno, M. A. Davis, E. Wong, H. A. Pasolli, A. B. Reynolds, and E. Fuchs, “p120-catenin mediates inflammatory responses in the skin,” Cell, vol. 124, no. 3, pp. 631–644, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Rattan, S. Giri, A. K. Singh, and I. Singh, “Rho a negatively regulates cytokine-mediated inducible nitric oxide synthase expression in brain-derived transformed cell lines: negative regulation of IKKα,” Free Radical Biology and Medicine, vol. 35, no. 9, pp. 1037–1050, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. X. Cao, C. Voss, B. Zhao, T. Kaneko, and S. S.-C. Li, “Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 5, pp. 1455–1460, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Al Maruf and P. O'Brien, “Flutamide-induced cytotoxicity and oxidative stress in an in vitro rat hepatocyte system,” Oxidative Medicine and Cellular Longevity, vol. 2014, Article ID 398285, 9 pages, 2014. View at Publisher · View at Google Scholar
  27. T. Persichini, Z. Percario, E. Mazzon, M. Colasanti, S. Cuzzocrea, and G. Musci, “Copper activates the NF-κB pathway in vivo,” Antioxidants and Redox Signaling, vol. 8, no. 9-10, pp. 1897–1904, 2006. View at Publisher · View at Google Scholar · View at Scopus